Cárdenas-RodrÃguez, N.; Ignacio-MejÃa, I.; MejÃa-Barradas, C.M.; Ortega-Cuellar, D.; Muñoz-González, F.; Vargas-Hernández, M.A.; Albores-Méndez, E.M.; Ibáñez-Cervantes, G.; Medina-Santillán, R.; Hernández-Ortiz, A.;
et al. Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants. Antioxidants 2025, 14, 840.
https://doi.org/10.3390/antiox14070840
AMA Style
Cárdenas-RodrÃguez N, Ignacio-MejÃa I, MejÃa-Barradas CM, Ortega-Cuellar D, Muñoz-González F, Vargas-Hernández MA, Albores-Méndez EM, Ibáñez-Cervantes G, Medina-Santillán R, Hernández-Ortiz A,
et al. Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants. Antioxidants. 2025; 14(7):840.
https://doi.org/10.3390/antiox14070840
Chicago/Turabian Style
Cárdenas-RodrÃguez, NoemÃ, Iván Ignacio-MejÃa, César Miguel MejÃa-Barradas, Daniel Ortega-Cuellar, Felipe Muñoz-González, Marco Antonio Vargas-Hernández, Exsal Manuel Albores-Méndez, Gabriela Ibáñez-Cervantes, Roberto Medina-Santillán, Aarón Hernández-Ortiz,
and et al. 2025. "Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants" Antioxidants 14, no. 7: 840.
https://doi.org/10.3390/antiox14070840
APA Style
Cárdenas-RodrÃguez, N., Ignacio-MejÃa, I., MejÃa-Barradas, C. M., Ortega-Cuellar, D., Muñoz-González, F., Vargas-Hernández, M. A., Albores-Méndez, E. M., Ibáñez-Cervantes, G., Medina-Santillán, R., Hernández-Ortiz, A., Herrera-López, E., & Bandala, C.
(2025). Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants. Antioxidants, 14(7), 840.
https://doi.org/10.3390/antiox14070840
